MD Anderson Cancer Center

Supporter

Membership discount for your BMC & SpringerOpen article processing charges (APCs)

As an affiliated author, a membership discount is available on your APC.

Please follow the submission guidelines to benefit from this membership discount.

View the submission guidelines

MD Anderson Cancer Center's Articles

MD Anderson Cancer Center's articles RSS

Page 62 of 64

Application of protein lysate microarrays to molecular marker verification and quantification

Authors: Anitha Ramaswamy, E Lin, Iou Chen, Rahul Mitra, Joel Morrisett, Kevin Coombes, Zhenlin Ju and Mini Kapoor

Citation: Proteome Science 2005 3:9

Content type: Methodology

Published on: 10 November 2005
The natural history of EGFR and EGFRvIII in glioblastoma patients

Authors: Amy B Heimberger, Dima Suki, David Yang, Weiming Shi and Kenneth Aldape

Citation: Journal of Translational Medicine 2005 3:38

Content type: Research

Published on: 19 October 2005
Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells

Authors: Paige J Baugher, Lakshmi Krishnamoorthy, Janet E Price and Surangani F Dharmawardhane

Citation: Breast Cancer Research 2005 7:R965

Content type: Research article

Published on: 30 September 2005
Attenuated Expression of DFFB is a Hallmark of Oligodendrogliomas with 1p-Allelic Loss

Authors: J Matthew McDonald, Valerie Dunmire, Ellen Taylor, Raymond Sawaya, Janet Bruner, Gregory N Fuller, Kenneth Aldape and Wei Zhang

Citation: Molecular Cancer 2005 4:35

Content type: Research

Published on: 12 September 2005
Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion

Authors: Lingegowda S Mangala, Banu Arun, Aysegul A Sahin and Kapil Mehta

Citation: Molecular Cancer 2005 4:33

Content type: Research

Published on: 9 September 2005
Effects of dietary curcumin or N-acetylcysteine on NF-κB activity and contractile performance in ambulatory and unloaded murine soleus

Authors: Mehran Farid, Michael B Reid, Yi-Ping Li, Eric Gerken and William J Durham

Citation: Nutrition & Metabolism 2005 2:20

Content type: Research

Published on: 26 August 2005
Overcoming cisplatin resistance by mTOR inhibitor in lung cancer

Authors: Chunjing Wu, Medhi Wangpaichitr, Lynn Feun, Marcus Tien Kuo, Carlos Robles, Theodore Lampidis and Niramol Savaraj

Citation: Molecular Cancer 2005 4:25

Content type: Research

Published on: 20 July 2005
Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitro

Authors: Emmanual Unni, Dimpy Koul, Wai-Kwan Alfred Yung and Raghu Sinha

Citation: Breast Cancer Research 2005 7:R699

Content type: Research article

Published on: 6 July 2005
WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome

Authors: María I Nunez, Daniel G Rosen, John H Ludes-Meyers, Martín C Abba, Hyunsuk Kil, Robert Page, Andres JP Klein-Szanto, Andrew K Godwin, Jinsong Liu, Gordon B Mills and C Marcelo Aldaz

Citation: BMC Cancer 2005 5:64

Content type: Research article

Published on: 27 June 2005
Ovarian cancer, the coagulation pathway, and inflammation

Authors: Xipeng Wang, Ena Wang, John J Kavanagh and Ralph S Freedman

Citation: Journal of Translational Medicine 2005 3:25

Content type: Review

Published on: 21 June 2005
Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells

Authors: Xinqun Li, Yang Lu, Ke Liang, Bolin Liu and Zhen Fan

Citation: Breast Cancer Research 2005 7:R589

Content type: Research article

Published on: 24 May 2005
Prime–boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu⁺metastatic breast cancer in mice

Authors: Xiaoyan Wang, Jian-Ping Wang, Xiao-Mei Rao, Janet E Price, Heshan S Zhou and Lawrence B Lachman

Citation: Breast Cancer Research 2005 7:R580

Content type: Research article

Published on: 23 May 2005
Acquisition of anoikis resistance in human osteosarcoma cells does not alter sensitivity to chemotherapeutic agents

Authors: C Marcela Díaz-Montero and Bradley W McIntyre

Citation: BMC Cancer 2005 5:39

Content type: Research article

Published on: 13 April 2005
Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies

Authors: Francisco J Esteva, Carol D Cheli, Herbert Fritsche, Monica Fornier, Dennis Slamon, Robert P Thiel, Diana Luftner and Farooq Ghani

Citation: Breast Cancer Research 2005 7:R436

Content type: Research article

Published on: 8 April 2005
In silico microdissection of microarray data from heterogeneous cell populations

Authors: Harri Lähdesmäki, llya Shmulevich, Valerie Dunmire, Olli Yli-Harja and Wei Zhang

Citation: BMC Bioinformatics 2005 6:54

Content type: Methodology article

Published on: 14 March 2005
Gene expression signature of estrogen receptor α status in breast cancer

Authors: Martín C Abba, Yuhui Hu, Hongxia Sun, Jeffrey A Drake, Sally Gaddis, Keith Baggerly, Aysegul Sahin and C Marcelo Aldaz

Citation: BMC Genomics 2005 6:37

Content type: Research article

Published on: 11 March 2005
Increased glutamate synaptic transmission in the nucleus raphe magnus neurons from morphine-tolerant rats

Authors: Bihua Bie and Zhizhong Z Pan

Citation: Molecular Pain 2005 1:7

Content type: Research

Published on: 9 February 2005
Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion

Authors: Eun-Ju Lee, Cristian Mircean, Ilya Shmulevich, Huamin Wang, Jinsong Liu, Antti Niemistö, John J Kavanagh, Je-Ho Lee and Wei Zhang

Citation: Molecular Cancer 2005 4:7

Content type: Research

Published on: 2 February 2005
Clinical significance of BRAF mutations in metastatic melanoma

Authors: David Z Chang, Katherine S Panageas, Iman Osman, David Polsky, Klaus Busam and Paul B Chapman

Citation: Journal of Translational Medicine 2004 2:46

Content type: Research

Published on: 21 December 2004
The docking protein Gab1 is the primary mediator of EGF-stimulated activation of the PI-3K/Akt cell survival pathway

Authors: Dawn R Mattoon, Betty Lamothe, Irit Lax and Joseph Schlessinger

Citation: BMC Biology 2004 2:24

Content type: Research article

Published on: 18 November 2004

You are viewing the site in preview mode

MD Anderson Cancer Center

MD Anderson Cancer Center's Articles

Application of protein lysate microarrays to molecular marker verification and quantification

The natural history of EGFR and EGFRvIII in glioblastoma patients

Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells

Attenuated Expression of DFFB is a Hallmark of Oligodendrogliomas with 1p-Allelic Loss

Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion

Effects of dietary curcumin or N-acetylcysteine on NF-κB activity and contractile performance in ambulatory and unloaded murine soleus

Overcoming cisplatin resistance by mTOR inhibitor in lung cancer

Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitro

WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome

Ovarian cancer, the coagulation pathway, and inflammation

Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells

Prime–boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu⁺metastatic breast cancer in mice

Acquisition of anoikis resistance in human osteosarcoma cells does not alter sensitivity to chemotherapeutic agents

Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies

In silico microdissection of microarray data from heterogeneous cell populations

Gene expression signature of estrogen receptor α status in breast cancer

Increased glutamate synaptic transmission in the nucleus raphe magnus neurons from morphine-tolerant rats

Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion

Clinical significance of BRAF mutations in metastatic melanoma

The docking protein Gab1 is the primary mediator of EGF-stimulated activation of the PI-3K/Akt cell survival pathway